文献速递慢性肾脏病肾血管病与高血压

SGLT2抑制剂改善年龄相关肾脏微血管稀疏

Sodium-glucose co-transporter 2 inhibition improves age-dependent kidney microvascular rarefaction.
PubMed 文献 · Kidney Int · 2025-12-23

本研究利用非洲绿松石鳉鱼(一种自然短寿命脊椎动物)探究肾脏衰老的自然进程,并用达格列净抑制SGLT2以测试干预效果。老年鳉鱼肾脏出现肾小球硬化、肾小管萎缩和血管稀疏,SGLT2i可减轻年龄相关血管稀疏、保留功能性毛细血管网络、减少白蛋白尿并维持年轻转录组特征。

要点

  • 老年鳉鱼肾脏呈现肾小球硬化、肾小管萎缩及微血管稀疏等衰老特征。
  • SGLT2i减轻年龄相关血管稀疏并保留功能性毛细血管网络。
  • SGLT2i减少白蛋白尿并维持更年轻的转录组谱。

核心结论

  • SGLT2i可保护肾脏微血管结构与功能,减少蛋白尿,并维持更年轻的转录组,支持其血管保护作用以缓解年龄相关肾脏退化。

研究设计与样本

  • 使用非洲绿松石鳉鱼(Nothobranchius furzeri)研究肾脏衰老自然进程,并用达格列净抑制SGLT2进行干预。
  • 采用组织学、免疫荧光和3D血管成像评估肾小球、肾小管、血管及功能变化,并对全肾进行单核转录组分析。

主要发现

  • 老年鳉鱼肾脏表现出肾小球硬化、肾小管萎缩和血管稀疏等衰老特征。
  • 功能变化包括蛋白尿增加和肾小管转运功能改变。
  • 转录组分析显示代谢从氧化磷酸化向糖酵解转变,促炎通路上调。
  • 衰老血管中紧密连接和细胞间接触显著减少。
  • SGLT2i减轻年龄相关血管稀疏、保留功能性毛细血管网络、减少白蛋白尿、维持年轻转录组谱并增强关键细胞间信号通路。

临床怎么用

  • SGLT2i可能通过血管保护作用延缓年龄相关肾脏微血管稀疏和功能下降。
  • 对于年龄相关肾脏退化,SGLT2i或可减少蛋白尿并维持肾脏微血管结构。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Aging is associated with progressive loss of kidney function and vascular structure, with and without chronic kidney disease. However, the mechanisms driving kidney vascular aging and potential therapeutic interventions remain poorly understood. METHODS: African turquoise killifish (Nothobranchius furzeri), a naturally short-lived vertebrate, were used to investigate the natural course of kidney aging. We inhibited the sodium-glucose co-transporter 2 using dapagliflozin (SGLT2i) to test a potential therapeutic intervention. Histological, immunofluorescent, and 3D vascular imaging were used to evaluate glomerular, tubular, vascular and functional changes. Single nuclei transcriptomic profiling was performed on whole kidneys to identify age, sex and treatment-associated molecular signatures. RESULTS: Aged killifish kidneys exhibited hallmark features of kidney aging, including glomerulosclerosis, tubular atrophy, and vascular rarefaction. Functional changes included increased proteinuria and altered tubular transporter function. Transcriptomic profiling revealed a metabolic shift from oxidative phosphorylation to glycolysis and upregulation of pro-inflammatory pathways. Aged vasculature displayed a marked reduction in tight junctions and cell-cell contacts. SGLT2i attenuated age-related vascular rarefaction, preserved functional capillary networks, reduced albuminuria, preserved a youthful transcriptional profile and enhanced key intercellular signaling pathways. CONCLUSIONS: Our study establishes the killifish as a translational model for investigating kidney vascular aging. SGLT2i preserves kidney microvascular structure and function, reduces proteinuria, and maintains a more youthful transcriptome. These results support a vascular-protective role of SGLT2i in mitigating age-related kidney deterioration.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Paulmann A, Cox MD, Boewer T, et al. Sodium-glucose co-transporter 2 inhibition improves age-dependent kidney microvascular rarefaction. Kidney Int. 2025. PMID: 41448458. doi:10.1016/j.kint.2025.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。